NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
Back to search
Official data from USPTO
JEPREFI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
06/25/2024
Trademark type
Word
Nice classes
5
Filing date
04/23/2021
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
06/25/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
MCNAMARA, SHANA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/22/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/20/2024
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
02/06/2024
FINA
FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
03/15/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/31/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/04/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/04/2023
CRTP
REG. CANCELLED - RESTORED TO PENDENCY
05/13/2022
APET
ASSIGNED TO PETITION STAFF
05/11/2022
RCII
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
05/06/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
02/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/26/2021
PUBO
PUBLISHED FOR OPPOSITION
10/26/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/17/2021
DOCK
ASSIGNED TO EXAMINER
09/06/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
07/31/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/09/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/09/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/25/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
06/24/2021
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
06/17/2021
Continuous trademark protection
Get notified about every new filing that threatens JEPREFI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.